Setting up of the European Liquid Biopsy Society (ELBS)

The main goal of the ELBS is to foster the introduction of liquid biopsy into clinical practice but it is also concerned with encouraging interactions between academia and industry, providing a partner for regulatory agencies, healthcare providers and patient advocacy groups, supporting the implementation of liquid biopsy tests into clinical trials, developing guidelines and providing training in liquid biopsy for medical scientists, disseminating the knowledge about liquid biopsies to the medical community through regular symposia, publications and press release, and more generally, increasing the visibility of Europe as leading hub for liquid biopsy research.

News Section

Social Media

CANCER-ID is supported by the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115749, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme and EFPIA companies´ in kind contribution.